Search

Your search keyword '"Schouten, Harry C."' showing total 347 results
Start Over Author "Schouten, Harry C." Publication Year Range Last 10 years
347 results on '"Schouten, Harry C."'

3. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

Author

Onida, Francesco, Sbianchi, Giulia, Radujkovic, Aleksandar, Sockel, Katja, Kröger, Nicolaus, Sierra, Jorge, Socié, Gerard, Cornelissen, Jan, Poiré, Xavier, Raida, Luděk, Bourhis, Jean Henri, Finke, Jürgen, Passweg, Jakob, Salmenniemi, Urpu, Schouten, Harry C., Beguin, Yves, Martin, Sonja, Deconinck, Eric, Ganser, Arnold, Zver, Samo, Lioure, Bruno, Rohini, Radia, Koster, Linda, Hayden, Patrick, Iacobelli, Simona, Robin, Marie, and Yakoub-Agha, Ibrahim

Published
2022
Full Text
View/download PDF

4. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation

Author

Brunstein, Claudio G, Pasquini, Marcelo C, Kim, Soyoung, Fei, Mingwei, Adekola, Kehinde, Ahmed, Ibrahim, Aljurf, Mahmoud, Agrawal, Vaibhav, Auletta, Jeffrey J, Battiwalla, Minoo, Bejanyan, Nelli, Bubalo, Joseph, Cerny, Jan, Chee, Lynette, Ciurea, Stefan O, Freytes, Cesar, Gadalla, Shahinaz M, Gale, Robert Peter, Ganguly, Siddhartha, Hashmi, Shahrukh K, Hematti, Peiman, Hildebrandt, Gerhard, Holmberg, Leona A, Lahoud, Oscar B, Landau, Heather, Lazarus, Hillard M, de Lima, Marcos, Mathews, Vikram, Maziarz, Richard, Nishihori, Taiga, Norkin, Maxim, Olsson, Richard, Reshef, Ran, Rotz, Seth, Savani, Bipin, Schouten, Harry C, Seo, Sachiko, Wirk, Baldeep M, Yared, Jean, Mineishi, Shin, Rogosheske, John, and Perales, Miguel-Angel

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Oncology and Carcinogenesis, Hematology, Rare Diseases, Transplantation, Lymphoma, Clinical Research, Cancer, Obesity, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Good Health and Well Being, Adult, Aged, Antineoplastic Agents, Drug Dosage Calculations, Female, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Mortality, Multiple Myeloma, Recurrence, Transplantation Conditioning, Transplantation, Autologous, Autologous hematopoietic cell transplantation, Conditioning regimen, Clinical Sciences, Immunology, Cardiovascular medicine and haematology
Abstract

Data are limited on whether to adjust high-dose chemotherapy before autologous hematopoietic cell transplant (autoHCT) in obese patients. This study explores the effects of dose adjustment on the outcomes of obese patients, defined as body mass index (BMI) ≥ 30 kg/m2. Dose adjustment was defined as a reduction in standard dosing ≥20%, based on ideal, reported dosing and actual weights. We included 2 groups of US patients who had received autoHCT between 2008 and 2014. Specifically, we included patients with multiple myeloma (MM, n = 1696) treated with high-dose melphalan and patients with Hodgkin or non-Hodgkin lymphomas (n = 781) who received carmustine, etoposide, cytarabine, and melphalan conditioning. Chemotherapy dose was adjusted in 1324 patients (78%) with MM and 608 patients (78%) with lymphoma. Age, sex, BMI, race, performance score, comorbidity index, and disease features (stage at diagnosis, disease status, and time to transplant) were similar between dose groups. In multivariate analyses for MM, adjusting for melphalan dose and for center effect had no impact on overall survival (P = .894) and treatment-related mortality (TRM) (P = .62), progression (P = .12), and progression-free survival (PFS; P = .178). In multivariate analyses for lymphoma, adjusting chemotherapy doses did not affect survival (P = .176), TRM (P = .802), relapse (P = .633), or PFS (P = .812). No center effect was observed in lymphoma. This study demonstrates that adjusting chemotherapy dose before autoHCT in obese patients with MM and lymphoma does not influence mortality. These results do not support adjusting chemotherapy dose in this population.

Published
2019

6. Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients' and hematology nurses’ perspectives and experiences

Author

van Lieshout, Rianne, Lize, Nora, Tick, Lidwine W., van Deursen, Judith, Driessen, Eline, Janssen, Tina, Custers, Stephanie, Kranenburg, Suzanne, van der Lee, Debbie, Koene, Harry R., Beckers, Erik A.M., Schouten, Harry C., and Beijer, Sandra

Published
2022
Full Text
View/download PDF

7. Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Author

Robin, Christine, Cordonnier, Catherine, Tridello, Gloria, Knelange, Nina, Xhaard, Alienor, Chantepie, Sylvain, Tanguy-Schmidt, Aline, Schouten, Harry C., Yeshurun, Moshe, Rocha, Vanderson, Srour, Micha, Kröger, Nicolaus, Ledoux, Marie-Pierre, Dalgaard, Jakob, Thiebaut, Anne, Giardino, Stefano, Calore, Elisabetta, Zuckerman, Tsila, Groll, Andreas H., Raida, Ludek, Avcin, Simona, Vicent, Marta Gonzalez, Kaare, Ain, Drozd-Sokolowska, Joanna, Turlure, Pascal, Bretagne, Stéphane, Mikulska, Malgorzata, Camara, Rafael de la, Cesaro, Simone, and Styczynski, Jan

Published
2024
Full Text
View/download PDF

8. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes

Author

Nazha, Aziz, Hu, Zhen-Huan, Wang, Tao, Lindsley, R. Coleman, Abdel-Azim, Hisham, Aljurf, Mahmoud, Bacher, Ulrike, Bashey, Asad, Cahn, Jean-Yves, Cerny, Jan, Copelan, Edward, DeFilipp, Zachariah, Diaz, Miguel Angel, Farhadfar, Nosha, Gadalla, Shahinaz M., Gale, Robert Peter, George, Biju, Gergis, Usama, Grunwald, Michael R., Hamilton, Betty, Hashmi, Shahrukh, Hildebrandt, Gerhard C., Inamoto, Yoshihiro, Kalaycio, Matt, Kamble, Rammurti T., Kharfan-Dabaja, Mohamed A., Lazarus, Hillard M., Liesveld, Jane L., Litzow, Mark R., Majhail, Navneet S., Murthy, Hemant S., Nathan, Sunita, Nishihori, Taiga, Pawarode, Attaphol, Rizzieri, David, Sabloff, Mitchell, Savani, Bipin N., Schachter, Levanto, Schouten, Harry C., Seo, Sachiko, Shah, Nirav N., Solh, Melhem, Valcárcel, David, Vij, Ravi, Warlick, Erica, Wirk, Baldeep, Wood, William A., Yared, Jean A., Alyea, Edwin, Popat, Uday, Sobecks, Ronald M., Scott, Bart L., Nakamura, Ryotaro, and Saber, Wael

Published
2020
Full Text
View/download PDF

10. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

Author

DeFilipp, Zachariah, Ancheta, Richard, Liu, Ying, Hu, Zhen-Huan, Gale, Robert Peter, Snyder, David, Schouten, Harry C., Kalaycio, Matt, Hildebrandt, Gerhard C., Ustun, Celalettin, Daly, Andrew, Ganguly, Siddhartha, Inamoto, Yoshihiro, Litzow, Mark, Szer, Jeffrey, Savoie, Mary Lynn, Hossain, Nasheed, Kharfan-Dabaja, Mohamed A., Hamadani, Mehdi, Reshef, Ran, Bajel, Ashish, Schultz, Kirk R., Gadalla, Shahinaz, Gerds, Aaron, Liesveld, Jane, Juckett, Mark B., Kamble, Rammurti, Hashmi, Shahrukh, Abdel-Azim, Hisham, Solh, Melhem, Bacher, Ulrike, Lazarus, Hillard, Olsson, Richard, Cahn, Jean-Yves, Grunwald, Michael R., Savani, Bipin N., Yared, Jean, Rowe, Jacob M., Cerny, Jan, Chaudhri, Naeem A., Aljurf, Mahmoud, Beitinjaneh, Amer, Seo, Sachiko, Nishihori, Taiga, Hsu, Jack W., Ramanathan, Muthalagu, Alyea, Edwin, Popat, Uday, Sobecks, Ronald, and Saber, Wael

Published
2020
Full Text
View/download PDF

11. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation

Author

Ballen, Karen, Ahn, Kwang Woo, Chen, Min, Abdel-Azim, Hisham, Ahmed, Ibrahim, Aljurf, Mahmoud, Antin, Joseph, Bhatt, Ami S, Boeckh, Michael, Chen, George, Dandoy, Christopher, George, Biju, Laughlin, Mary J, Lazarus, Hillard M, MacMillan, Margaret L, Margolis, David A, Marks, David I, Norkin, Maxim, Rosenthal, Joseph, Saad, Ayman, Savani, Bipin, Schouten, Harry C, Storek, Jan, Szabolcs, Paul, Ustun, Celalettin, Verneris, Michael R, Waller, Edmund K, Weisdorf, Daniel J, Williams, Kirsten M, Wingard, John R, Wirk, Baldeep, Wolfs, Tom, Young, Jo-Anne H, Auletta, Jeffrey, Komanduri, Krishna V, Lindemans, Caroline, and Riches, Marcie L

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Immunology, Rare Diseases, Stem Cell Research, Infectious Diseases, Clinical Research, Regenerative Medicine, Transplantation, Hematology, Stem Cell Research - Nonembryonic - Human, 2.2 Factors relating to the physical environment, Aetiology, Infection, Good Health and Well Being, Acute Disease, Adolescent, Adult, Aged, Cord Blood Stem Cell Transplantation, Female, Hematopoietic Stem Cell Transplantation, Histocompatibility, Humans, Incidence, Infections, Leukemia, Male, Middle Aged, Retrospective Studies, Survival Analysis, Unrelated Donors, Young Adult, Umbilical cord blood, Clinical Sciences, Cardiovascular medicine and haematology
Abstract

Alternative graft sources (umbilical cord blood [UCB], matched unrelated donors [MUD], or mismatched unrelated donors [MMUD]) enable patients without a matched sibling donor to receive potentially curative hematopoietic cell transplantation (HCT). Retrospective studies demonstrate comparable outcomes among different graft sources. However, the risk and types of infections have not been compared among graft sources. Such information may influence the choice of a particular graft source. We compared the incidence of bacterial, viral, and fungal infections in 1781 adults with acute leukemia who received alternative donor HCT (UCB, n= 568; MUD, n = 930; MMUD, n = 283) between 2008 and 2011. The incidences of bacterial infection at 1 year were 72%, 59%, and 65% (P

Published
2016

12. Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Author

Robin, Christine, primary, Cordonnier, Catherine, additional, Tridello, Gloria, additional, Knelange, Nina, additional, Xhaard, Alienor, additional, Chantepie, Sylvain, additional, Tanguy-Schmidt, Aline, additional, Schouten, Harry C, additional, Yesherun, Moshe, additional, Rocha, Vanderson, additional, Srour, Micha, additional, Kröger, Nicolaus, additional, Ledoux, Marie-Pierre, additional, Dalgaard, Jakob, additional, Thiebaut, Anne, additional, Giardino, Stefano, additional, Calore, Elisabetta, additional, Zuckerman, Tsila, additional, Groll, Andreas H, additional, Raida, Ludek, additional, Avcin, Simona, additional, Vicent, Marta Gonzalez, additional, Kaare, Ain, additional, Drozd-Sokolowska, Joanna, additional, Turlure, Pascal, additional, Bretagne, Stéphane, additional, Mikulska, Malgorzata, additional, Camara, Rafael de la, additional, Cesaro, Simone, additional, and Styczynski, Jan, additional

Published
2023
Full Text
View/download PDF

17. Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation

Author

Saad, Ayman, Lamb, Lawrence, Wang, Tao, Hemmer, Michael T., Spellman, Stephen, Couriel, Daniel, Alousi, Amin, Pidala, Joseph, Abdel-Azim, Hisham, Agrawal, Vaibhav, Aljurf, Mahmoud, Beitinjaneh, Amer M., Bhatt, Vijaya Raj, Buchbinder, David, Byrne, Michael, Cahn, Jean-Yves, Cairo, Mitchell, Castillo, Paul, Chhabra, Saurabh, Diaz, Miguel Angel, Farhan, Shatha, Floisand, Yngvar, Frangoul, Hadar A., Gadalla, Shahinaz M., Gajewski, James, Gale, Robert Peter, Gandhi, Manish, Gergis, Usama, Hamilton, Betty Ky, Hematti, Peiman, Hildebrandt, Gerhard C., Kamble, Rammurti T., Kanate, Abraham S., Khandelwal, Pooja, Lazaryan, Aleksandr, MacMillan, Margaret, Marks, David I., Martino, Rodrigo, Mehta, Parinda A., Nishihori, Taiga, Olsson, Richard F., Patel, Sagar S., Qayed, Muna, Rangarajan, Hemalatha G., Reshef, Ran, Ringden, Olle, Savani, Bipin N., Schouten, Harry C., Schultz, Kirk R., Seo, Sachiko, Shaffer, Brian C., Solh, Melhem, Teshima, Takanori, Urbano-Ispizua, Alvaro, Verdonck, Leo F., Vij, Ravi, Waller, Edmund K., William, Basem, Wirk, Baldeep, Yared, Jean A., Yu, Lolie C., Arora, Mukta, and Hashmi, Shahrukh

Published
2019
Full Text
View/download PDF

19. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma

Author

Radivoyevitch, Tomas, Dean, Robert M., Shaw, Bronwen E., Brazauskas, Ruta, Tecca, Heather R., Molenaar, Remco J., Battiwalla, Minoo, Savani, Bipin N., Flowers, Mary E.D., Cooke, Kenneth R., Hamilton, Betty K., Kalaycio, Matt, Maciejewski, Jaroslaw P., Ahmed, Ibrahim, Akpek, Görgün, Bajel, Ashish, Buchbinder, David, Cahn, Jean-Yves, D’Souza, Anita, Daly, Andrew, DeFilipp, Zachariah, Ganguly, Siddhartha, Hamadani, Mehdi, Hayashi, Robert J., Hematti, Peiman, Inamoto, Yoshihiro, Khera, Nandita, Kindwall-Keller, Tamila, Landau, Heather, Lazarus, Hillard, Majhail, Navneet S., Marks, David I., Olsson, Richard F., Seo, Sachiko, Steinberg, Amir, William, Basem M., Wirk, Baldeep, Yared, Jean A., Aljurf, Mahmoud, Abidi, Muneer H., Allewelt, Heather, Beitinjaneh, Amer, Cook, Rachel, Cornell, Robert F., Fay, Joseph W., Hale, Gregory, Chakrabarty, Jennifer Holter, Jodele, Sonata, Kasow, Kimberly A., Mahindra, Anuj, Malone, Adriana K., Popat, Uday, Rizzo, J. Douglas, Schouten, Harry C., Warwick, Anne B., Wood, William A., Sekeres, Mikkael A., Litzow, Mark R., Gale, Robert P., and Hashmi, Shahrukh K.

Published
2018
Full Text
View/download PDF

21. Changes in nutritional status and associations with physical and clinical outcomes in acute myeloid leukemia patients during intensive chemotherapy

Author

van Lieshout, Rianne, Tick, Lidwine W., Beckers, Erik A. M., Biesbroek, Willemijn, Dieleman, Jeanne P., Dijkstra, Myrthe, Groenesteijn, Wanda, Koene, Harry R., Kranenburg, Suzanne, van der Lee, Debbie, van der Put - van den Berg, Liesbeth, Rademakers, Nicky, Regelink, Josien C., van Tilborg, Claudia J., Westerweel, Peter E., de Zeeuw, Sandra, Schouten, Harry C., and Beijer, Sandra

Abstract

Background/Objectives: Patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) often receive medical nutrition therapy (MNT) during intensive remission-induction treatment. Since little is known about changes in nutritional status, specifically body composition, in this patient population, these changes and their associations with physical and clinical outcomes were assessed. Subjects/Methods: In this multicenter prospective observational study, newly diagnosed AML/MDS patients who received intensive remission-induction chemotherapy, routine dietary counseling by a dietician and MNT immediately upon inadequate nutritional intake, were included. At treatment initiation and discharge, nutritional status, including Patient-Generated Subjective Global Assessment (PG-SGA)-scores and body composition, physical outcomes and fatigue were assessed. Associations of nutritional status/body composition with physical outcomes, fatigue, fever duration, number of complications, time to neutrophil engraftment and hospital length of stay (LOS) (collected from medical records) were examined using multiple regression analysis. Results: In >91% of the 126 AML/MDS patients included, nutritional intake was adequate, with 61% receiving MNT. Nevertheless, body weight decreased significantly (p< 0.001) and mainly consisted of a loss of muscle/fat-free mass (FFM) (p< 0.001), while fat mass (FM) remained unchanged (p-value range = 0.71–0.77). Body weight and waist circumference showed significant negative associations with fever duration and/or number of complications. Significant positive associations were found between mid-upper arm muscle circumference (MUAMC) and physical functioning and between PG-SGA-scores and fatigue. Body weight and MUAMC were also negatively associated with LOS. Conclusion: Despite MNT in AML/MDS patients undergoing intensive chemotherapy, muscle/FFM decreased while FM remained unchanged. Maintenance of nutritional status was associated with improved physical and clinical outcomes.

Published
2024
Full Text
View/download PDF

22. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Author

Muffly, Lori, Pasquini, Marcelo C., Martens, Michael, Brazauskas, Ruta, Zhu, Xiaochun, Adekola, Kehinde, Aljurf, Mahmoud, Ballen, Karen K., Bajel, Ashish, Baron, Frederic, Battiwalla, Minoo, Beitinjaneh, Amer, Cahn, Jean-Yves, Carabasi, Mathew, Chen, Yi-Bin, Chhabra, Saurabh, Ciurea, Stefan, Copelan, Edward, D'Souza, Anita, Edwards, John, Foran, James, Freytes, Cesar O., Fung, Henry C., Gale, Robert Peter, Giralt, Sergio, Hashmi, Shahrukh K., Hildebrandt, Gerhard C., Ho, Vincent, Jakubowski, Ann, Lazarus, Hillard, Luskin, Marlise R., Martino, Rodrigo, Maziarz, Richard, McCarthy, Philip, Nishihori, Taiga, Olin, Rebecca, Olsson, Richard F., Pawarode, Attaphol, Peres, Edward, Rezvani, Andrew R., Rizzieri, David, Savani, Bipin N., Schouten, Harry C., Sabloff, Mitchell, Seftel, Matthew, Seo, Sachiko, Sorror, Mohamed L., Szer, Jeff, Wirk, Baldeep M., Wood, William A., and Artz, Andrew

Published
2017
Full Text
View/download PDF

23. Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

Author

Harrison, Claire N, Schaap, Nicolaas, Vannucchi, Alessandro M, Kiladjian, Jean-Jacques, Tiu, Ramon V, Zachee, Pierre, Jourdan, Eric, Winton, Elliott, Silver, Richard T, Schouten, Harry C, Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Lager, Joanne, Shun, Zhenming, and Mesa, Ruben A

Published
2017
Full Text
View/download PDF

24. Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Author

Löwenberg, Bob, Pabst, Thomas, Maertens, Johan, van Norden, Yvette, Biemond, Bart J., Schouten, Harry C., Spertini, Olivier, Vellenga, Edo, Graux, Carlos, Havelange, Violaine, de Greef, Georgine E., de Weerdt, Okke, Legdeur, Marie-Cecile J.C., Kuball, Juergen, Kooy, Marinus van Marwijk, Gjertsen, Bjorn T., Jongen-Lavrencic, Mojca, van de Loosdrecht, Arjan A., van Lammeren-Venema, Daniëlle, Hodossy, Beata, Breems, Dimitri A., Chalandon, Yves, Passweg, Jakob, Valk, Peter J.M., Manz, Markus G., and Ossenkoppele, Gert J.

Published
2017
Full Text
View/download PDF

25. Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

Author

Turcotte, Lucie M., Wang, Tao, Hemmer, Michael T., Spellman, Stephen R., Arora, Mukta, Couriel, Daniel, Alousi, Amin, Pidala, Joseph, Abdel-Azim, Hisham, Ahmed, Ibrahim, Beitinjaneh, Amer, Buchbinder, David, Byrne, Michael, Callander, Natalie, Chao, Nelson, Choi, Sung Wong, DeFilipp, Zachariah, Gadalla, Shahinaz M., Gale, Robert Peter, Gergis, Usama, Hashmi, Shahrukh, Hematti, Peiman, Holmberg, Leona, Inamoto, Yoshihiro, Kamble, Rammurti T., Lehmann, Leslie, MacMillan, Margaret A., McIver, Zachariah, Nishihori, Taiga, Norkin, Maxim, O’Brien, Tracey, Olsson, Richard F., Reshef, Ran, Saad, Ayman, Savani, Bipin N., Schouten, Harry C., Seo, Sachiko, Solh, Melhem, Verdonck, Leo, Vij, Ravi, Wirk, Baldeep, Yared, Jean, Horowitz, Mary M., Knight, Jennifer M., and Verneris, Michael R.

Published
2018
Full Text
View/download PDF

26. Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study

Author

Bejanyan, Nelli, Zhang, Meijie, Bo-Subait, Khalid, Brunstein, Claudio, Wang, Hailin, Warlick, Erica D., Giralt, Sergio, Nishihori, Taiga, Martino, Rodrigo, Passweg, Jakob, Dias, Ajoy, Copelan, Edward, Hale, Gregory, Gale, Robert Peter, Solh, Melhem, Kharfan-Dabaja, Mohamed A., Diaz, Miguel Angel, Ganguly, Siddhartha, Gore, Steven, Verdonck, Leo F., Hossain, Nasheed M., Kekre, Natasha, Savani, Bipin, Byrne, Michael, Kanakry, Christopher, Cairo, Mitchell S., Ciurea, Stefan, Schouten, Harry C., Bredeson, Christopher, Munker, Reinhold, Lazarus, Hillard, Cahn, Jean-Yves, van Der Poel, Marjolein, Rizzieri, David, Yared, Jean A., Freytes, Cesar, Cerny, Jan, Aljurf, Mahmoud, Palmisiano, Neil D., Pawarode, Attaphol, Bacher, Vera Ulrike, Grunwald, Michael R., Nathan, Sunita, Wirk, Baldeep, Hildebrandt, Gerhard C., Seo, Sachiko, Olsson, Richard F., George, Biju, de Lima, Marcos, Hourigan, Christopher S., Sandmaier, Brenda M., Litzow, Mark, Kebriaei, Partow, Saber, Wael, and Weisdorf, Daniel

Published
2021
Full Text
View/download PDF

27. Supplemental Table 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Data from Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

Author

Kim, Haesook T., primary, Ahn, Kwang Woo, primary, Hu, Zhen-Huan, primary, Davids, Matthew S., primary, Volpe, Virginia O., primary, Antin, Joseph H., primary, Sorror, Mohamed L., primary, Shadman, Mazyar, primary, Press, Oliver, primary, Pidala, Joseph, primary, Hogan, William, primary, Negrin, Robert, primary, Devine, Steven, primary, Uberti, Joseph, primary, Agura, Edward, primary, Nash, Richard, primary, Mehta, Jayesh, primary, McGuirk, Joseph, primary, Forman, Stephen, primary, Langston, Amelia, primary, Giralt, Sergio A., primary, Perales, Miguel-Angel, primary, Battiwalla, Minoo, primary, Hale, Gregory A., primary, Gale, Robert Peter, primary, Marks, David I., primary, Hamadani, Mehdi, primary, Ganguly, Sid, primary, Bacher, Ulrike, primary, Lazarus, Hillard, primary, Reshef, Ran, primary, Hildebrandt, Gerhard C., primary, Inamoto, Yoshihiro, primary, Cahn, Jean-Yves, primary, Solh, Melhem, primary, Kharfan-Dabaja, Mohamed A., primary, Ghosh, Nilanjan, primary, Saad, Ayman, primary, Aljurf, Mahmoud, primary, Schouten, Harry C., primary, Hill, Brian T., primary, Pawarode, Attaphol, primary, Kindwall-Keller, Tamila, primary, Saba, Nakhle, primary, Copelan, Edward A., primary, Nathan, Sunita, primary, Beitinjaneh, Amer, primary, Savani, Bipin N., primary, Cerny, Jan, primary, Grunwald, Michael R., primary, Yared, Jean, primary, Wirk, Baldeep M., primary, Nishihori, Taiga, primary, Chhabra, Saurabh, primary, Olsson, Richard F., primary, Bashey, Asad, primary, Gergis, Usama, primary, Popat, Uday, primary, Sobecks, Ronald, primary, Alyea, Edwin, primary, Saber, Wael, primary, and Brown, Jennifer R., primary

Published
2023
Full Text
View/download PDF

29. Supplemental Figure 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

30. Supplemental Table 2 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

32. Supplemental Table 3 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

33. Supplemental Table 4 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Data from Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

Author

Baron, Frédéric, primary, Labopin, Myriam, primary, Ruggeri, Annalisa, primary, Cornelissen, Jan J., primary, Meijer, Ellen, primary, Sengeloev, Henrik, primary, Niederwieser, Dietger, primary, De Groot, Marco R., primary, Schouten, Harry C., primary, Milpied, Noel, primary, Blaise, Didier, primary, Savani, Bipin N., primary, Gluckman, Eliane, primary, Mohty, Mohamad, primary, and Nagler, Arnon, primary

Published
2023
Full Text
View/download PDF

35. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT

Author

DeFilipp, Zachariah, Duarte, Rafael F., Snowden, John A., Majhail, Navneet S., Greenfield, Diana M., Miranda, José López, Arat, Mutlu, Baker, K. Scott, Burns, Linda J., Duncan, Christine N., Gilleece, Maria, Hale, Gregory A., Hamadani, Mehdi, Hamilton, Betty K., Hogan, William J., Hsu, Jack W., Inamoto, Yoshihiro, Kamble, Rammurti T., Lupo-Stanghellini, Maria Teresa, Malone, Adriana K., McCarthy, Philip, Mohty, Mohamad, Norkin, Maxim, Paplham, Pamela, Ramanathan, Muthalagu, Richart, John M., Salooja, Nina, Schouten, Harry C., Schoemans, Helene, Seber, Adriana, Steinberg, Amir, Wirk, Baldeep M., Wood, William A., Battiwalla, Minoo, Flowers, Mary E.D., Savani, Bipin N., and Shaw, Bronwen E.

Published
2016
Full Text
View/download PDF

36. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

Author

Martino, Massimo, Lanza, Francesco, Pavesi, Lorenzo, Öztürk, Mustafa, Blaise, Didier, Leno Núñez, Rubén, Schouten, Harry C., Bosi, Alberto, De Giorgi, Ugo, Generali, Daniele, Rosti, Giovanni, Necchi, Andrea, Ravelli, Andrea, Bengala, Carmelo, Badoglio, Manuela, Pedrazzoli, Paolo, and Bregni, Marco

Published
2016
Full Text
View/download PDF

37. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

Author

Pasquini, Marcelo C., Zhang, Mei-Jie, Medeiros, Bruno C., Armand, Philippe, Hu, Zhen-Huan, Nishihori, Taiga, Aljurf, Mahmoud D., Akpek, Görgün, Cahn, Jean-Yves, Cairo, Mitchell S., Cerny, Jan, Copelan, Edward A., Deol, Abhinav, Freytes, César O., Gale, Robert Peter, Ganguly, Siddhartha, George, Biju, Gupta, Vikas, Hale, Gregory A., Kamble, Rammurti T., Klumpp, Thomas R., Lazarus, Hillard M., Luger, Selina M., Liesveld, Jane L., Litzow, Mark R., Marks, David I., Martino, Rodrigo, Norkin, Maxim, Olsson, Richard F., Oran, Betul, Pawarode, Attaphol, Pulsipher, Michael A., Ramanathan, Muthalagu, Reshef, Ran, Saad, Ayman A., Saber, Wael, Savani, Bipin N., Schouten, Harry C., Ringdén, Olle, Tallman, Martin S., Uy, Geoffrey L., Wood, William A., Jr., Wirk, Baldeep, Pérez, Waleska S., Batiwalla, Minoo, and Weisdorf, Daniel J.

Published
2016
Full Text
View/download PDF

38. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

Author

Urbano-Ispizua, Alvaro, Pavletic, Steven Z., Flowers, Mary E., Klein, John P., Zhang, Mei-Jie, Carreras, Jeanette, Montoto, Silvia, Perales, Miguel-Angel, Aljurf, Mahmoud D., Akpek, Görgün, Bredeson, Christopher N., Costa, Luciano J., Dandoy, Christopher, Freytes, César O., Fung, Henry C., Gale, Robert Peter, Gibson, John, Hamadani, Mehdi, Hayashi, Robert J., Inamoto, Yoshihiro, Inwards, David J., Lazarus, Hillard M., Maloney, David G., Martino, Rodrigo, Munker, Reinhold, Nishihori, Taiga, Olsson, Richard F., Rizzieri, David A., Reshef, Ran, Saad, Ayman, Savani, Bipin N., Schouten, Harry C., Smith, Sonali M., Socié, Gérard, Wirk, Baldeep, Yu, Lolie C., and Saber, Wael

Published
2015
Full Text
View/download PDF

40. Center for International Blood and Marrow Transplant Research Chronic Graft-versus-Host Disease Risk Score Predicts Mortality in an Independent Validation Cohort

Author

Arora, Mukta, Hemmer, Michael T., Ahn, Kwang Woo, Klein, John P., Cutler, Corey S., Urbano-Ispizua, Alvaro, Couriel, Daniel R., Alousi, Amin M., Gale, Robert Peter, Inamoto, Yoshihiro, Weisdorf, Daniel J., Li, Peigang, Antin, Joseph H., Bolwell, Brian J., Boyiadzis, Michael, Cahn, Jean-Yves, Cairo, Mitchell S., Isola, Luis M., Jacobsohn, David A., Jagasia, Madan, Klumpp, Thomas R., Petersdorf, Effie W., Santarone, Stella, Schouten, Harry C., Wingard, John R., Spellman, Stephen R., Pavletic, Steven Z., Lee, Stephanie J., Horowitz, Mary M., and Flowers, Mary E.D.

Published
2015
Full Text
View/download PDF

41. Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation

Author

Copelan, Edward A., Avalos, Belinda R., Ahn, Kwang Woo, Zhu, Xiaochun, Gale, Robert Peter, Grunwald, Michael R., Hamadani, Mehdi, Hamilton, Betty K., Hale, Gregory A., Marks, David I., Waller, Edmund K., Savani, Bipin N., Costa, Luciano J., Ramanathan, Muthalagu, Cahn, Jean-Yves, Khoury, H. Jean, Weisdorf, Daniel J., Inamoto, Yoshihiro, Kamble, Rammurti T., Schouten, Harry C., Wirk, Baldeep, Litzow, Mark R., Aljurf, Mahmoud D., van Besien, Koen W., Ustun, Celalettin, Bolwell, Brian J., Bredeson, Christopher N., Fasan, Omotayo, Ghosh, Nilanjan, Horowitz, Mary M., Arora, Mukta, Szer, Jeffrey, Loren, Alison W., Alyea, Edwin P., Cortes, Jorge, Maziarz, Richard T., Kalaycio, Matt E., and Saber, Wael

Published
2015
Full Text
View/download PDF

42. Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Author

Duncan, Christine N., Majhail, Navneet S., Brazauskas, Ruta, Wang, Zhiwei, Cahn, Jean-Yves, Frangoul, Haydar A., Hayashi, Robert J., Hsu, Jack W., Kamble, Rammurti T., Kasow, Kimberly A., Khera, Nandita, Lazarus, Hillard M., Loren, Alison W., Marks, David I., Maziarz, Richard T., Mehta, Paulette, Myers, Kasiani C., Norkin, Maxim, Pidala, Joseph A., Porter, David L., Reddy, Vijay, Saber, Wael, Savani, Bipin N., Schouten, Harry C., Steinberg, Amir, Wall, Donna A., Warwick, Anne B., Wood, William A., Yu, Lolie C., Jacobsohn, David A., and Sorror, Mohamed L.

Published
2015
Full Text
View/download PDF

44. Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Author

Sharma, Manish, Zhang, Mei-Jie, Zhong, Xiaobo, Abidi, Muneer H., Akpek, Görgün, Bacher, Ulrike, Callander, Natalie S., Dispenzieri, Angela, Freytes, César O., Fung, Henry C., Gale, Robert Peter, Gasparetto, Cristina, Gibson, John, Holmberg, Leona A., Kindwall-Keller, Tamila L., Klumpp, Thomas R., Krishnan, Amrita Y., Landau, Heather J., Lazarus, Hillard M., Lonial, Sagar, Maiolino, Angelo, Marks, David I., Mehta, Paulette, Mikhael, Joseph R., Nishihori, Taiga, Olsson, Richard, Ramanathan, Muthalagu, Roy, Vivek, Savani, Bipin N., Schouten, Harry C., Scott, Emma, Tay, Jason, To, Luen Bik, Vesole, David H., Vogl, Dan T., and Hari, Parameswaran

Published
2014
Full Text
View/download PDF

45. Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning

Author

Ringdén, Olle, Brazauskas, Ruta, Wang, Zhiwei, Ahmed, Ibrahim, Atsuta, Yoshiko, Buchbinder, David, Burns, Linda J., Cahn, Jean-Yves, Duncan, Christine, Hale, Gregory A., Halter, Joerg, Hayashi, Robert J., Hsu, Jack W., Jacobsohn, David A., Kamble, Rammurti T., Kamani, Naynesh R., Kasow, Kimberly A., Khera, Nandita, Lazarus, Hillard M., Loren, Alison W., Marks, David I., Myers, Kasiani C., Ramanathan, Muthalagu, Saber, Wael, Savani, Bipin N., Schouten, Harry C., Socie, Gérard, Sorror, Mohamed L., Steinberg, Amir, Popat, Uday, Wingard, John R., Mattsson, Jonas, and Majhail, Navneet S.

Published
2014
Full Text
View/download PDF

46. Long-term effects after stem cell transplantation identified: design of the MOSA study

Author

Wauben, Bianca, van Yperen, Nicole C, van der Poel, Marjolein Wm, Köhler, Sebastian, van Greevenbroek, Marleen Mj, Schouten, Harry C, Interne Geneeskunde, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Hematologie (9), Psychiatrie & Neuropsychologie, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, and RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome

Subjects
MARROW TRANSPLANTATION, SURVIVORS, COMPLICATIONS, LATE MORTALITY, Cohort studies, Hematopoietic stem cell transplantation, Study design, FOLLOW-UP, General population controls, Long-term adverse effects
Abstract

OBJECTIVE: The MOSA study (Maastricht Observational study of late effects after Stem cell trAnsplantation) aims to study the prevalence of adverse health effects in hematopoietic stem cell transplantation (HCT) survivors compared to a matched cohort, representing the general population. STUDY DESIGN AND SETTING: The MOSA study is a matched cohort study, nested within a large prospective cohort, The Maastricht Study. Participants of The Maastricht Study serve as a reference group matched on age, sex and education to compare MOSA participants to the general population. In both studies, the same study protocol and extensive phenotyping measurements are used. RESULTS: HCT survivors: 539 survivors were invited of which, so far 123 (23%) participants completed the study assessments. Data will be analyzed and published separately. REFERENCE GROUP: For each MOSA participant, four reference cases were matched. After matching, both groups are comparable with respect to age, sex and education. CONCLUSION: To our knowledge, this is the first study conducting such detailed phenotyping in HCT survivors. Comparison with a large reference group provides essential information about late effects of HCT and associated risk factors. This may improve screening and prevention strategies, potentially leading to a positive impact on morbidity, mortality and quality of life.

Published
2022

49. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

Author

Ruggeri, Annalisa, Labopin, Myriam, Bacigalupo, Andrea, Afanasyev, Boris, Cornelissen, Jan J., Elmaagacli, Ahmet, Itälä-Remes, Maija, Blaise, Didier, Meijer, Ellen, Koc, Yener, Milpied, Noel, Schouten, Harry C., Kroeger, Nicolaus, Mohty, Mohamad, and Nagler, Arnon

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results